SEC Filing Analysis: Guardant Health, Inc. (GH)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director for Guardant Health acquired 250 shares through the vesting of Restricted Stock Units (RSUs), a routine compensation event with no cash value.
• Market Impact: Neutral. This transaction is non-discretionary and does not reflect a new investment decision by the insider.

Company Information

Field	Value
Company	Guardant Health, Inc.
Ticker Symbol	GH
CIK	0001576280
Industry	SERVICES-MEDICAL LABORATORIES

Insider Information

Field	Value
Name	Tariq Musa
CIK	0001968281
Title/Position	Director
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-12-15
Transaction Code	M (Exercise/Vesting of derivative)
Security Type	Common Stock
Shares Involved	250
Price Per Share	$0.00
Total Value	$0
Shares Owned After	8,109
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.00%
Shares Transacted	250
% of Shares Outstanding	Not available
Post-Transaction Ownership	8,109 shares (Ownership % not available)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction has a value of $0, making it entirely immaterial to Guardant Health's $12.26 billion market capitalization.
• Ownership Concentration: The insider's post-transaction holdings of 8,109 shares are a minor stake. A full assessment is not possible without shares outstanding data.
• Dilution Impact: This vesting event stems from an RSU grant made in March 2023. The potential dilution was already known to the market at the time of the grant. The vesting of 250 shares has a negligible dilutive effect.
• Transaction Significance: The transaction is rated as Low significance. It is a non-cash, pre-scheduled compensation event (RSU vesting) and does not represent a new investment decision or change in the insider's sentiment.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The vesting of RSUs is a routine part of executive compensation and does not provide new information to the market. It is not an open-market transaction and carries no investment signal.

Volume & Sentiment

• Expected Volume Impact: Negligible. No shares were sold on the open market as part of this specific filing.
• Sentiment Indicator: Neutral. This filing is informational and does not imply a bullish or bearish outlook from the insider.

Additional Context

Transaction Notes

• Special Circumstances: The transaction is the result of RSUs vesting. According to the filing's footnotes, these RSUs were granted on March 6, 2023, and vest over a four-year period. This event is part of that pre-determined vesting schedule.